OGN
Organon & Co.

1,381
Mkt Cap
$1.94B
Volume
5.32M
52W High
$17.23
52W Low
$6.18
PE Ratio
3.87
OGN Fundamentals
Price
$7.13
Prev Close
$7.43
Open
$7.44
50D MA
$9.02
Beta
0.91
Avg. Volume
6.41M
EPS (Annual)
$3.33
P/B
2.14
Rev/Employee
$640,300.00
Loading...
Loading...
News
all
press releases
Organon & Co. (OGN) is Attracting Investor Attention: Here is What You Should Know
Zacks.com users have recently been watching Organon (OGN) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.
Zacks·2d ago
News Placeholder
More News
News Placeholder
Henlius and Organon Announce US FDA Approval of POHERDY (pertuzumab-dpzb), the First PERJETA (pertuzumab) Biosimilar in the US
Shanghai Henlius Biotech, Inc. (2696.HK), and Organon (NYSE: OGN) today announced that the US Food and Drug Administration (FDA) has approved the Biologics License Application (BLA) for POHERDY...
Business Wire·4d ago
News Placeholder
Campbell & CO Investment Adviser LLC Takes Position in Organon & Co. $OGN
Campbell & CO Investment Adviser LLC acquired a new stake in Organon & Co. (NYSE:OGN - Free Report) during the second quarter, according to its most recent Form 13F filing with the SEC. The firm...
MarketBeat·5d ago
News Placeholder
AE Wealth Management LLC Reduces Holdings in Organon & Co. $OGN
AE Wealth Management LLC lowered its position in Organon & Co. (NYSE:OGN - Free Report) by 74.8% during the second quarter, according to its most recent 13F filing with the Securities and Exchange...
MarketBeat·5d ago
News Placeholder
M&G PLC Purchases 496,362 Shares of Organon & Co. $OGN
M&G PLC boosted its position in Organon & Co. (NYSE:OGN - Free Report) by 133.7% during the 2nd quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange...
MarketBeat·6d ago
News Placeholder
Organon & Co. (NYSE:OGN) Price Target Cut to $12.00 by Analysts at JPMorgan Chase & Co.
JPMorgan Chase & Co. lowered their price objective on shares of Organon & Co. from $14.00 to $12.00 and set an "underweight" rating on the stock in a research note on Tuesday...
MarketBeat·8d ago
News Placeholder
Organon & Co. (NYSE:OGN) Declares Quarterly Dividend of $0.02
Organon & Co. (NYSE:OGN) declared a quarterly dividend on Monday, November 10th. Shareholders of record on Thursday, November 20th will be given a dividend of 0.02 per share on Thursday, December...
MarketBeat·9d ago
News Placeholder
Organon & Co. (NYSE:OGN) Shares Up 10.9% - Should You Buy?
Organon & Co. (NYSE:OGN) Trading Up 10.9% - Here's What Happened...
MarketBeat·9d ago
News Placeholder
Organon & Co. (NYSE:OGN) Announces Quarterly Earnings Results, Hits Expectations
Organon & Co. (NYSE:OGN - Get Free Report) announced its quarterly earnings results on Monday. The company reported $0.93 EPS for the quarter, meeting analysts' consensus estimates of $0.93. Organon...
MarketBeat·9d ago
News Placeholder
Organon (OGN) Q3 Earnings: Taking a Look at Key Metrics Versus Estimates
Although the revenue and EPS for Organon (OGN) give a sense of how its business performed in the quarter ended September 2025, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.
Zacks·10d ago

Latest OGN News

View

Advertisement|Remove ads.

Advertisement|Remove ads.